MONTH 1 Meet with your care team to review your goals, health history, and begin your GLP-1 treatment with a plan tailored specifically to you
For someone already considering a GLP-1 for weight or diabetes, this data adds a factor on the benefit side
Never use a 1 mL syringe with 60 mg/mL tirzepatide, because the markings are too far apart to distinguish between doses that differ by several milligrams
Weeks 1-4: 2mg weekly (both of us) Weeks 5-8: 4mg weekly Weeks 9-12: 8mg weekly Week 13 onward: 12mg weekly Injected subcutaneously in the abdomen, rotated sites each week
The primary mechanism of action involves: Stimulating insulin secretion in a glucose-dependent manner Suppressing glucagon release when blood glucose is elevated Slowing gastric emptying to promote satiety Acting on central nervous system pathways that regulate appetite For type 2 diabetes, these medications typically reduce hemoglobin A1c by 1.01.5%
Together, youll create sustainable changes to help you reach your goals